Skip to main content
Clinical Trials/NCT02120612
NCT02120612
Completed
N/A

Increasing Patient Knowledge of the Signs of Opioid Overdose and Naloxone in a Suburban Treatment Program

Edward Hospital1 site in 1 country100 target enrollmentApril 2014

Overview

Phase
N/A
Intervention
Not specified
Conditions
Opioid Dependence
Sponsor
Edward Hospital
Enrollment
100
Locations
1
Primary Endpoint
Opiate Overdose Knowledge Scale (OOKS)
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The purpose of this study is to determine the effect that an educational intervention has on patient knowledge of the signs of opioid overdose and appropriate use of naloxone in a suburban outpatient treatment program.

Detailed Description

The outpatient Addiction Services program at Linden Oaks will begin implementing an educational program on the signs of opioid overdose and naloxone for all patients who have a diagnosis of opiate dependence in the investigators suburban treatment program. Subjects will be recruited from that population and administered a new, empirically validated scale (i.e. the Opiate Overdose Knowledge Scale; OOKS) both pre- and post-intervention to measure the effect that the educational program has on patient knowledge. Patients will also be surveyed (i.e. History Survey) about their experiences over the previous 12-months (e.g. exposure to opiate overdoses, access/use of naloxone) prior to treatment; and, this History Survey will then be re-administered by phone, 1-3 months after discharge. The aim is to measure whether education influences patient behavior. Finally, all subjects will be administered an empirically-validated measure to assess subject shame and guilt (i.e. Guilt and Shame Proneness Scale; GASP), and response patterns in their behavior, to evaluate whether shame and guilt predict behavior at follow-up. The investigators will compare to data (i.e. OOKS, GASP, and History Survey) from a historical control group prior to the implementation of the educational program - and, also at 1-3 month follow-up.

Registry
clinicaltrials.gov
Start Date
April 2014
End Date
July 2020
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adult subjects who have been diagnosed with a DSM opioid use disorder by LOH staff.

Exclusion Criteria

  • Subjects who are deemed to have moderate to severe cognitive impairment - as assessed by standard psychiatric evaluation from Linden Oaks clinical staff - will be excluded from the study.

Outcomes

Primary Outcomes

Opiate Overdose Knowledge Scale (OOKS)

Time Frame: 0-3 months

The Opiate Overdose Knowledge Scale (OOKS) is an empirically-validated scale that measures knowledge of: (1) the risks, warning signs, and life-saving steps to take regarding an opioid overdose; and, (2) the appropriate use of naloxone.

Secondary Outcomes

  • Guilt and Shame Proneness Scale (GASP)(0-3 months)
  • History Survey(0-3 months)

Study Sites (1)

Loading locations...

Similar Trials